1 completed, 1 withdrawn. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow Cholestasis, progressive familial intrahepatic 2: new trials by email Literature Review of Cholestasis, progressive familial intrahepatic 2 trials Research Report on Cholestasis, progressive familial intrahepatic 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BSEP Function Rescue During Childhood Inhereditary Cholestatic Diseases 4-Phenylbutyrate - Hereditary Diseases, Cholestasis, Intrahepatic | Phase 2 / Phase 3 | Withdrawn | Children's Hospital of Fudan University | 2023-02-08 | 2023-02-09 | |
| Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition pravastatin and chenodeoxycholic acid, after metformin and placebo, valacyclovir, chenodeoxycholic acid, and enalaprilat, after polysorbate 80 and placebo - Bile Salt Export Pump (BSEP) Transporter, Polysorbate 80 | Phase 4 | Completed | University of Maryland, Baltimore | 18 | 2021-04-01 | 2024-07-16 |
Cholestasis, Intrahepatic (1) · Genetic Diseases, Inborn (1)
Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholestasis (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Liver Diseases (1)
4-phenylbutyric acid (1) · Chenodeoxycholic Acid (1) · Enalaprilat (1) · Pravastatin (1) · Ursodeoxycholic Acid (1) · Valacyclovir (1)
Children's Hospital of Fudan University (1) · University of Maryland, Baltimore (1)
United States (1)